Research Summaries

Upcoming Events

How Might Exercise Impact the Sexual Function of Patients With Prostate Cancer

How Might Exercise Impact the Sexual Function of Patients With Prostate Cancer

Introduction

Sexual difficulties are a common and distressing side effect of prostate cancer and its treatment. Patients who experience sexual dysfunction (e.g., erectile dysfunction (ED), loss of sexual desire, or both) after having a prostatectomy or undergoing radiation or hormone therapy may also struggle with the psychological and relational ramifications of this change. For example, they may experience a loss of self-confidence regarding their body image and sexual performance and/or worry about not being able to satisfy their sexual partner(s).

Male Genital Self-Image Scale (MGSIS) Validated in Brazil

Male Genital Self-Image Scale (MGSIS) Validated in Brazil

Introduction

A person’s perception of their body and its features can impact their quality of life as well as their mental, emotional, and sexual well-being. Those who do not feel good about their bodies may be more prone to low self-esteem, depression, anxiety, and social isolation.

The Role of Androgens in the Sexual Function of Women with Rectal Cancer

The Role of Androgens in the Sexual Function of Women with Rectal Cancer

Introduction

Women who survive rectal cancer may experience sexual difficulties or dysfunction during and after treatment. Chemotherapy, radiotherapy, and rectal surgery can impact urinary, bowel, and sexual function. According to previous studies, 60% of women report an increase in vaginal dryness and dyspareunia (painful intercourse) after rectal cancer treatment. There is also a high incidence of reduced sexual desire and decline in frequency of sexual activity for rectal cancer survivors.

Standardized Survey Assesses Patient’s Satisfaction With Penile Implants

Standardized Survey Assesses Patient’s Satisfaction With Penile Implants

Development and Validation of the Satisfaction Survey for Inflatable Penile Implant (SSIPI)

Carolyn A. Salter MD; Philip Vu Bach MD; Lawrence Jenkins MD; Nelson Bennett MD; Faysal A. Yafi MD; Farouk el Khatib MD; Elizabeth Schofield MPH; Nicole Benfante MS; Stanley E. Althof PhD; Christian J. Nelson PhD; John P. Mulhall MD, MSc, FECSM, FACS

FIRST PUBLISHED: August 6, 2021 – The Journal of Sexual Medicine 

DOI: https://doi.org/10.1016/j.jsxm.2021.06.020 

A Quarter of Peyronie’s Disease Patients Choose Xiaflex Injections

A Quarter of Peyronie’s Disease Patients Choose Xiaflex Injections

Predictors of Pursuing Intralesional Xiaflex in Peyronie’s Disease Patients

Nahid Punjani MD, MPH; Bruno Nascimento MD; Carolyn Salter MD; Jose Flores MD; Eduardo Miranda MD; Jean Terrier MD; Hisanori Taniguchi MD;

Lawrence Jenkins MD; John P. Mulhall MD, MSc, FECSM, FACS

FIRST PUBLISHED: July 3, 2021 – The Journal of Sexual Medicine

DOI: https://doi.org/10.1016/j.jsxm.2021.05.006

Peyronie’s Disease: Should Nonresponders Receive Entire CCH Injection Protocol?

Continuing Collagenase Clostridium Histolyticum Injections Among Initial Nonresponders Results in Significant Curvature Improvements in the Majority of Peyronie’s Disease Men

Manaf Alom MBBS; Holli Burgon BS; Matthew Ziegelmann MD; Tobias Köhler MD; Sevann Helo MD; Landon Trost MD

Image

Members Only

Newsletter

ISSM Update